TLX2 and chronic kidney disease: In this study, KB‐R7943, a NCX blocker, inhibited the occurrence, beating rate, and duration of tachypacing‐induced VT in the isoproterenol‐treated CKD RVOT tissues, but KN93 and H89 only shortened its duration.